With ‘Perspectives – Art, Inflammation and Me’, the pharma company hopes to add a different dimension to the understanding of immune-mediated inflammatory diseases (IMIDs) and their impact.
The initiative brings together more than 200 artists with patients in over 40 countries. They have created a series of paintings, sculptures, photos and other artistic expressions that vividly depict the impact of IMIDs, which include rheumatoid arthritis, Crohn’s disease and ankylosing spondylitis.
Inspired by patients’ stories, artists and art students created each piece to help more people better understand the burdens associated with some of these chronic and debilitating conditions
Copies of these marvellous artistic expressions were exhibited at Seleni Suites in Vytina from 6 to 8 November 2016.